{
    "clinical_study": {
        "@rank": "50214", 
        "acronym": "RH", 
        "arm_group": {
            "arm_group_label": "Resistant Hypertension", 
            "description": "The current definition of resistant hypertension (RH) includes both patients whose blood pressure (BP) is uncontrolled on three or more medications and those whose BP is controlled when using four or more antihypertensive medications"
        }, 
        "brief_summary": {
            "textblock": "The contribution of this study is the unedited evaluation of the circadian autonomic\n      profiles of resistant hypertension  with and without white-coat response."
        }, 
        "brief_title": "Autonomic Dysfunction in Resistant Hypertension", 
        "completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "condition": "Hypertension, Resistant to Conventional Therapy", 
        "condition_browse": {
            "mesh_term": "Hypertension"
        }, 
        "detailed_description": {
            "textblock": "All patients were submitted to office blood pressure measurement, Ambulatory blood pressure\n      monitoring and 24-hour Holter monitoring.\n\n      Baseline blood samples for the measurement of glycemia (mg/dL), total cholesterol (mg/dL),\n      LDL cholesterol (mg/dL), triglycerides (mg/dL), creatinine (mg/dL), serum uric acid, serum\n      sodium, serum potassium, plasma aldosterone concentration (PAC) and plasma renin activity\n      (PRA) were collected at 08:00 after overnight fasting."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  resistant hypertensive patients\n\n        Exclusion Criteria:\n\n          -  White-coat hypertension\n\n          -  obstructive sleep apnea"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "30 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Forty-four resistant hypertension subjects, regularly followed up at the cardiovascular\n        clinical pharmacology out-patients' clinic, and who complied with pharmacological\n        prescription for hypertension, were recruited to participate in this transversal and\n        observational study."
            }
        }, 
        "enrollment": {
            "#text": "44", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 5, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01833429", 
            "org_study_id": "907/2011"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Resistant hypertension", 
            "White-coat phenomenon", 
            "Heart rate variability", 
            "autonomic activity"
        ], 
        "lastchanged_date": "April 12, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Campinas", 
                    "country": "Brazil", 
                    "state": "Sao Paulo", 
                    "zip": "13083-888"
                }, 
                "name": "Cardiovascular Pharmacology Laboratory"
            }
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_groups": "1", 
        "official_title": "Circadian Autonomic Disturbances in Resistant Hypertension With and Without White-coat Phenomenon", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Brazil: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The autonomic nervous system can be assessed by the heart rate variability. Variations in heart rate variability  are normally observed in association with diurnal rhythms and blood pressure changes. The heart rate variability parameters are different in many studies, although the consensus is that lower values of the indices of vagal as well as high indices of sympathetic functions are associated prospectively with death and disability.\nIn humans, the disturbances of the circadian rhythms of heart rate variability and blood pressure have been intensively studied, mainly due to the increased cardiovascular death reported during the morning hours", 
            "measure": "evaluation of the autonomic function in resistant hypertensive patients", 
            "safety_issue": "No", 
            "time_frame": "10 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01833429"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Campinas, Brazil", 
            "investigator_full_name": "Val\u00e9ria Nasser Figueiredo", 
            "investigator_title": "PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "results_reference": [
            {
                "PMID": "18574054", 
                "citation": "Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM; American Heart Association Professional Education Committee. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008 Jun 24;117(25):e510-26."
            }, 
            {
                "PMID": "22215711", 
                "citation": "Muxfeldt ES, Fiszman R, de Souza F, Viegas B, Oliveira FC, Salles GF. Appropriate time interval to repeat ambulatory blood pressure monitoring in patients with white-coat resistant hypertension. Hypertension. 2012 Feb;59(2):384-9. doi: 10.1161/HYPERTENSIONAHA.111.185405. Epub 2012 Jan 3."
            }
        ], 
        "source": "University of Campinas, Brazil", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Campinas, Brazil", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2011", 
        "study_design": "Observational Model: Cohort", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "10 Months", 
        "verification_date": "February 2012"
    }
}